Johnson & Johnson said a second shot of its COVID-19 vaccine given about two months after the first increased its effectiveness to 94% against moderate to severe forms of the disease, according to data from the U.S. that is not peer reviewed.
#News #Reuters #COVID #DeltaVariant #Vaccine
Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.
Get the latest news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en